Health Care news, Health Care industry, industry News

▮ More

17 States Approve Centene's Acquisition Of WellCare - Quick Facts

Mobile Games Can Help Detect Cognitive Deterioration : Study

Former Canopy Growth Co-CEO Bruce Linton Invests In Slang Worldwide

FDA, Canada, Australia Collaborate On Cancer Drugs Review

AstraZeneca Amends Collaboration With Ironwood For Linzess In China

FDA Grants Breakthrough Therapy Designation For Genentech's Gazyva

CannTrust Stock Falls After Cannabis License Suspended By Health Canada

Danaher's Envista Prices IPO Of 26.77 Mln Shares At $22.00/shr

CompuGroup Medical Decides Share Buyback

Philips Launches Sleep Position Therapy Device - Quick Facts

Chick-fil-A Serving 'No Antibiotics Ever' Chicken At All U.S. Restaurants

Study To Examine Link Between Copper And Alzheimer's

Merck: FDA Grants Priority Review For Investigational Ebola Vaccine

Acceleron Pharma's ACE-083 Fails In Phase 2 Study For FSHD

AVITA Gets FDA IDE Approval Of Soft Tissue Reconstruction Pivotal Clinical Trial

Novartis: Cosentyx Phase III Trial Meets Primary Endpoint At Week 16

Novartis 16-week Phase III PREVENT Study Of ASAS40 Meets Primary Endpoint

Reports: Cannabis Testing Lab Fined $225K For Improper Marijuana Disposal

Accuray Investor Meeting At 4:00 PM ET

Astellas Pharma: FDA Grants Priority Review For Enfortumab Vedotin - Quick Facts

AstraZeneca Announces Fast Track Designation For FARXIGA - Quick Facts

AstraZeneca: FDA Grants Fast Track Designation For FARXIGA In Heart Failure

Zimmer Biomet : FDA Okays JuggerStitch Meniscal Repair Device

An 'Eye' For Alzheimer's Disease

AlivaMab Discovery Services Announces Multi-Target Agreement With Janssen

Industries >>

Health Care News

AstraZeneca Amends Collaboration With Ironwood For Linzess In China

FDA Grants Breakthrough Therapy Designation For Genentech's Gazyva

Novartis 16-week Phase III PREVENT Study Of ASAS40 Meets Primary Endpoint

AstraZeneca: FDA Grants Fast Track Designation For FARXIGA In Heart Failure

AlivaMab Discovery Services Announces Multi-Target Agreement With Janssen